Joy Wan1, Junko Takeshita2, Daniel B Shin3, Joel M Gelfand2. 1. Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: joywan@pennmedicine.upenn.edu. 2. Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 3. Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Atopic dermatitis (AD) is associated with mental health disorders, but its impact on global mental health symptoms is less clear. OBJECTIVE: To determine the association between pediatric AD and mental health impairment. METHODS: In a cross-sectional study using 2013-2017 United States National Health Interview Survey data, children with and without AD were assessed for mental disorder with impairment (MDI) using a validated behavioral screening questionnaire. Mental health services utilization was also reported. RESULTS: The prevalence of any MDI was 26.7% (95% confidence interval [CI], 25.1-28.3) among children with AD and 17.7% (95% CI, 17.2-18.2) among those without AD, with severe MDI being present in 10.9% (95% CI 9.9-12.1) and 6.2% (95% CI 5.9-6.5), respectively. Adjusted for sociodemographic factors, AD was associated with higher odds of MDI (odds ratio, 1.52; 95% CI, 1.39-1.67), including impairments in conduct, emotions, peer relationships, and attention. Among children with AD, 19.9% (95% CI, 16.6-23.8) and 53.5% (95% CI, 48.5-58.5) of those with mild or severe MDI, respectively, had seen a mental health professional in the last year. LIMITATIONS: Misclassification bias may arise from self-reported data. CONCLUSION: AD is associated with clinically significant mental health symptoms, but many affected children may not seek or receive care for their symptoms.
BACKGROUND:Atopic dermatitis (AD) is associated with mental health disorders, but its impact on global mental health symptoms is less clear. OBJECTIVE: To determine the association between pediatric AD and mental health impairment. METHODS: In a cross-sectional study using 2013-2017 United States National Health Interview Survey data, children with and without AD were assessed for mental disorder with impairment (MDI) using a validated behavioral screening questionnaire. Mental health services utilization was also reported. RESULTS: The prevalence of any MDI was 26.7% (95% confidence interval [CI], 25.1-28.3) among children with AD and 17.7% (95% CI, 17.2-18.2) among those without AD, with severe MDI being present in 10.9% (95% CI 9.9-12.1) and 6.2% (95% CI 5.9-6.5), respectively. Adjusted for sociodemographic factors, AD was associated with higher odds of MDI (odds ratio, 1.52; 95% CI, 1.39-1.67), including impairments in conduct, emotions, peer relationships, and attention. Among children with AD, 19.9% (95% CI, 16.6-23.8) and 53.5% (95% CI, 48.5-58.5) of those with mild or severe MDI, respectively, had seen a mental health professional in the last year. LIMITATIONS: Misclassification bias may arise from self-reported data. CONCLUSION:AD is associated with clinically significant mental health symptoms, but many affected children may not seek or receive care for their symptoms.
Authors: Anna B Fishbein; Kelly Mueller; Lacey Kruse; Peter Boor; Stephen Sheldon; Phyllis Zee; Amy S Paller Journal: J Am Acad Dermatol Date: 2017-10-28 Impact factor: 11.527
Authors: Michael S Blaiss; Eva Hammerby; Susan Robinson; Tessa Kennedy-Martin; Sarah Buchs Journal: Ann Allergy Asthma Immunol Date: 2018-04-04 Impact factor: 6.347
Authors: Danny Camfferman; John D Kennedy; Michael Gold; Alfred J Martin; Kurt Lushington Journal: Sleep Med Rev Date: 2010-04-14 Impact factor: 11.609
Authors: Karen H Bourdon; Robert Goodman; Donald S Rae; Gloria Simpson; Doreen S Koretz Journal: J Am Acad Child Adolesc Psychiatry Date: 2005-06 Impact factor: 8.829
Authors: Jon A Halvorsen; Lars Lien; Florence Dalgard; Espen Bjertness; Robert S Stern Journal: J Invest Dermatol Date: 2014-02-04 Impact factor: 8.551
Authors: Anna B Fishbein; Brian T Cheng; Caroline C Tilley; Wendy Smith Begolka; Adam C Carle; Christopher B Forrest; Phillis C Zee; Amy S Paller; James W Griffith Journal: J Allergy Clin Immunol Pract Date: 2021-05-12